nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—PTGDR—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0855	0.0978	CbGpPWpGaD
Nedocromil—HSP90AA1—pons—intracranial aneurysm	0.0611	0.487	CbGeAlD
Nedocromil—FPR1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.043	0.0492	CbGpPWpGaD
Nedocromil—HSP90AA1—eNOS activation—NOS3—intracranial aneurysm	0.0384	0.0439	CbGpPWpGaD
Nedocromil—CYSLTR2—Endothelins—EDNRA—intracranial aneurysm	0.0371	0.0424	CbGpPWpGaD
Nedocromil—HSP90AA1—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—intracranial aneurysm	0.0305	0.0349	CbGpPWpGaD
Nedocromil—CYSLTR1—Endothelins—EDNRA—intracranial aneurysm	0.0257	0.0294	CbGpPWpGaD
Nedocromil—FPR1—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—intracranial aneurysm	0.0238	0.0273	CbGpPWpGaD
Nedocromil—PTGDR—Thromboxane A2 receptor signaling—NOS3—intracranial aneurysm	0.0228	0.0261	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism of nitric oxide—NOS3—intracranial aneurysm	0.0211	0.0242	CbGpPWpGaD
Nedocromil—FPR1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.0202	0.0231	CbGpPWpGaD
Nedocromil—FPR1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0158	0.0181	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.0155	0.0178	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.0155	0.0177	CbGpPWpGaD
Nedocromil—PTGDR—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.0153	0.0175	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.0151	0.0172	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STARD13—intracranial aneurysm	0.0144	0.0164	CbGpPWpGaD
Nedocromil—PTGDR—brain—intracranial aneurysm	0.0142	0.113	CbGeAlD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.0139	0.0159	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STARD13—intracranial aneurysm	0.0139	0.0159	CbGpPWpGaD
Nedocromil—HSP90AA1—brainstem—intracranial aneurysm	0.0136	0.108	CbGeAlD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.0136	0.0155	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.0131	0.015	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.0128	0.0146	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NCF1—intracranial aneurysm	0.0121	0.0138	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.012	0.0137	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STARD13—intracranial aneurysm	0.0109	0.0124	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.0108	0.0123	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.0103	0.0118	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.0103	0.0118	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00998	0.0114	CbGpPWpGaD
Nedocromil—FPR1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00997	0.0114	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00962	0.011	CbGpPWpGaD
Nedocromil—HSP90AA1—medulla oblongata—intracranial aneurysm	0.00949	0.0756	CbGeAlD
Nedocromil—HSP90AA1—midbrain—intracranial aneurysm	0.00867	0.0691	CbGeAlD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00832	0.00951	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00783	0.00895	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.00762	0.00871	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STARD13—intracranial aneurysm	0.00754	0.00862	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00713	0.00815	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—CCL2—intracranial aneurysm	0.00671	0.00768	CbGpPWpGaD
Nedocromil—HSP90AA1—cerebellum—intracranial aneurysm	0.00671	0.0535	CbGeAlD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00668	0.00764	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RBBP8—intracranial aneurysm	0.00656	0.0075	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—AGER—intracranial aneurysm	0.00647	0.0074	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00646	0.00738	CbGpPWpGaD
Nedocromil—CYSLTR1—brain—intracranial aneurysm	0.00628	0.05	CbGeAlD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—MMP2—intracranial aneurysm	0.00628	0.00718	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00598	0.00684	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00584	0.00668	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00564	0.00645	CbGpPWpGaD
Nedocromil—HSP90AA1—brain—intracranial aneurysm	0.00545	0.0434	CbGeAlD
Nedocromil—CYSLTR1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00543	0.00621	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—intracranial aneurysm	0.00542	0.0062	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STARD13—intracranial aneurysm	0.00541	0.00619	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SLC25A16—intracranial aneurysm	0.00536	0.00613	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.0053	0.00606	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.0053	0.00606	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00512	0.00585	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00509	0.00582	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00507	0.00579	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NOS3—intracranial aneurysm	0.00501	0.00572	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CCL2—intracranial aneurysm	0.00492	0.00562	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—MMP9—intracranial aneurysm	0.00472	0.0054	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC25A16—intracranial aneurysm	0.00449	0.00513	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00442	0.00506	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTSS—intracranial aneurysm	0.00438	0.00501	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTSK—intracranial aneurysm	0.00403	0.00461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00402	0.00459	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CCL2—intracranial aneurysm	0.00386	0.00441	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00351	0.00402	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTSB—intracranial aneurysm	0.00334	0.00382	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NCF1—intracranial aneurysm	0.00332	0.00379	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NCF1—intracranial aneurysm	0.0032	0.00366	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00313	0.00358	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00307	0.00351	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EDNRA—intracranial aneurysm	0.00302	0.00346	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ASAH1—intracranial aneurysm	0.00297	0.0034	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00278	0.00318	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00267	0.00306	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00261	0.00299	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTSS—intracranial aneurysm	0.00255	0.00292	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CCL2—intracranial aneurysm	0.00252	0.00289	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NCF1—intracranial aneurysm	0.00251	0.00287	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00237	0.00271	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTSK—intracranial aneurysm	0.00235	0.00269	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP2—intracranial aneurysm	0.00233	0.00267	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AGER—intracranial aneurysm	0.00215	0.00246	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CST3—intracranial aneurysm	0.00205	0.00235	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00198	0.00226	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTSB—intracranial aneurysm	0.00194	0.00222	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NCF1—intracranial aneurysm	0.00193	0.00221	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NCF1—intracranial aneurysm	0.00179	0.00204	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP9—intracranial aneurysm	0.00175	0.002	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NCF1—intracranial aneurysm	0.00174	0.00199	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP2—intracranial aneurysm	0.00166	0.0019	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00165	0.00188	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCL2—intracranial aneurysm	0.00154	0.00176	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCL2—intracranial aneurysm	0.00149	0.0017	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOS3—intracranial aneurysm	0.00138	0.00157	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00137	0.00157	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOS3—intracranial aneurysm	0.00133	0.00152	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AGER—intracranial aneurysm	0.00125	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—intracranial aneurysm	0.00125	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NCF1—intracranial aneurysm	0.00125	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00118	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—intracranial aneurysm	0.00117	0.00134	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—intracranial aneurysm	0.0011	0.00126	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—intracranial aneurysm	0.00107	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—intracranial aneurysm	0.00104	0.00119	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—intracranial aneurysm	0.000836	0.000956	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000811	0.000927	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—intracranial aneurysm	0.000741	0.000847	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—intracranial aneurysm	0.000723	0.000826	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—intracranial aneurysm	0.00062	0.000709	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—intracranial aneurysm	0.000582	0.000665	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—intracranial aneurysm	0.00058	0.000663	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—intracranial aneurysm	0.000519	0.000593	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—intracranial aneurysm	0.000416	0.000476	CbGpPWpGaD
